Advanced search
Publication Cover
Patient Preference and Adherence Volume 18, 2024 - Issue
Submit an article Journal homepage
113
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Impact of Patient Adherence to Dual Antiplatelet Medication Following Percutaneous Coronary Intervention on the Occurrence of Adverse Cardiovascular Events

J A MansurovaDepartment of Therapy, Non-Commercial Joint-Stock Company “Semey Medical University”, Semey, The Republic of KazakhstanORCID Iconhttps://orcid.org/0000-0003-2439-2056View further author information
ORCID Icon,
Andrey OrekhovDepartment of Therapy, Non-Commercial Joint-Stock Company “Semey Medical University”, Semey, The Republic of KazakhstanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7201-1399View further author information
ORCID Icon,
A S ZhunuspekovaDepartment of Therapy, Non-Commercial Joint-Stock Company “Semey Medical University”, Semey, The Republic of KazakhstanORCID Iconhttps://orcid.org/0000-0002-2413-317XView further author information
ORCID Icon,
A A KassymovaDepartment of Therapy, Non-Commercial Joint-Stock Company “Semey Medical University”, Semey, The Republic of KazakhstanORCID Iconhttps://orcid.org/0000-0001-9333-4146View further author information
ORCID Icon &
L K KarazhanovaDepartment of Therapy, Non-Commercial Joint-Stock Company “Semey Medical University”, Semey, The Republic of KazakhstanView further author information
Pages 425-434 | Received 19 Nov 2023, Accepted 03 Feb 2024, Published online: 16 Feb 2024

References

  • Vedanthan R, Seligman B, Fuster V. Global perspective on acute coronary syndrome: a burden on the young and poor. Circ Res. 2014;114(12):1959–1975. doi:10.1161/CIRCRESAHA.114.302782
  • Collet JP, Thiele H, Barbatoet E. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
  • Dexter PR, Miller DK, Clark DO. Preparing for an Aging Population and Improving Chronic Disease Management. AMIA Annu Symp Proc. 2010;2010:162–166.
  • Cheng K, Ingram N, Keenan J, et al. Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies. Open Heart. 2015;2(1):e000166. doi:10.1136/openhrt-2014-000166
  • Anderson L, Brown JP, Clark AM. Patient education in the management of coronary heart disease. Cochrane Database Syst Rev. 2017;6(6):CD008895. doi:10.1002/14651858.CD008895.pub3
  • Chow CK, Klimis H, Thiagalingamet A, et al. Text Messages to Improve Medication Adherence and Secondary Prevention after Acute Coronary Syndrome: the TEXTMEDS Randomized Clinical Trial. Circulation. 2022;145(19):1443–1455. doi:10.1161/CIRCULATIONAHA.121.056161
  • Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2007;115(20):2675–2682. doi:10.1161/CIRCULATIONAHA.106.180945
  • Kabboul NN, Tomlinson G, Francis TA, et al. Comparative effectiveness of the core components of cardiac rehabilitation on mortality and morbidity: a systematic review and network meta-analysis. J Clin Med. 2018;7(12):514. doi:10.3390/jcm7120514
  • Morisky DE, Green LW, Morisky LD. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
  • Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393
  • Rodriguez F, Harrington RA. Management of Antithrombotic Therapy after Acute Coronary Syndromes. N Engl J Med. 2021;384(5):452–460. doi:10.1056/NEJMra1607714
  • Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842–1847. doi:10.1001/archinte.166.17.1842
  • Kourti O, Konstantas O, Farmakis IT, et al. Potent P2Y12 inhibitors versus clopidogrel to predict adherence to antiplatelet therapy after an acute coronary syndrome: insights from IDEAL-LDL. Rev Cardiovasc Med. 2022;23(3):81. doi:10.31083/j.rcm2303081
  • Batista Santos V, Silva LL, Guizilini S, et al. Adherence to antiplatelet and statin therapy by patients with acute coronary syndrome following discharge. Enferm Clin. 2022:32(2);115–122. doi:10.1016/j.enfcli.2020.02.020
  • Anderson L, Brown JPR, Clark AM. Patient education in the management of coronary heart disease (Review). Cochrane Database Syst Rev. 2017;6. doi:10.1002/14651858.CD008895.pub3
  • Cohen A, Assyag P, Boyer-Chatenet L, et al. An education program for risk factor management after an acute coronary syndrome a randomized clinical trial. JAMA Intern Med. 2014;174(1):40–48. doi:10.1001/jamainternmed.2013.11342
  • Chinwong S, Doungsong K, Channaina P, Phrommintikul A, Chinwong D. Association between medication adherence and cardiovascular outcomes among acute coronary syndrome patients. Res Social Adm Pharm. 2021;17(9):1631–1635. doi:10.1016/j.sapharm.2021.01.003

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.